Mylan’s abbreviated new drug application for morphine sulphate extended-release tablets has been approved by the US Food and Drug Administration (FDA) .
The tablets are available in doses of 15mg, 30mg, 60mg, 100mg and 200mg.
The dose formulations are the generic equivalent to Purdue Pharma’s MS Contin, an opioid analgesic for moderate-to-severe pain management.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData